Global Pharmacovigilance (Pv) Outsourcing Market Research Report 2025(Status and Outlook)
Report Overview
The global Pharmacovigilance (Pv) Outsourcing market size was estimated at USD 10268.75 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 9.65% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Pharmacovigilance (Pv) Outsourcing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Pharmacovigilance (Pv) Outsourcing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pharmacovigilance (Pv) Outsourcing market
Global Pharmacovigilance (Pv) Outsourcing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Accenture
C3i Solutions
Clintec
Covance
Deloitte Touche Tohmatsu Limited
ELC Group
Ergomed
iGATE Corporation
iMED Global Corporation
IQVIA
MarksMan Healthcare
Medpace Holdings
Novartis
Oracle Corporation
Parexel
PharmInvent
PrimeVigilance
Pure Drug Safety
Sciformix
SIRO Clinpharm
Symogen
Market Segmentation (by Type)
Contract Research Organizations (CROs)
Business Process Outsourcing (BPOs)
Market Segmentation (by Application)
Premarketing Clinical Trial
Post-marketing Clinical Practice
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmacovigilance (Pv) Outsourcing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Pharmacovigilance (Pv) Outsourcing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Pharmacovigilance (Pv) Outsourcing market size was estimated at USD 10268.75 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 9.65% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Pharmacovigilance (Pv) Outsourcing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Pharmacovigilance (Pv) Outsourcing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pharmacovigilance (Pv) Outsourcing market
Global Pharmacovigilance (Pv) Outsourcing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Accenture
C3i Solutions
Clintec
Covance
Deloitte Touche Tohmatsu Limited
ELC Group
Ergomed
iGATE Corporation
iMED Global Corporation
IQVIA
MarksMan Healthcare
Medpace Holdings
Novartis
Oracle Corporation
Parexel
PharmInvent
PrimeVigilance
Pure Drug Safety
Sciformix
SIRO Clinpharm
Symogen
Market Segmentation (by Type)
Contract Research Organizations (CROs)
Business Process Outsourcing (BPOs)
Market Segmentation (by Application)
Premarketing Clinical Trial
Post-marketing Clinical Practice
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Pharmacovigilance (Pv) Outsourcing Market
- Overview of the regional outlook of the Pharmacovigilance (Pv) Outsourcing Market.
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmacovigilance (Pv) Outsourcing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Pharmacovigilance (Pv) Outsourcing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Pharmacovigilance (Pv) Outsourcing
1.2 Key Market Segments
1.2.1 Pharmacovigilance (Pv) Outsourcing Segment by Type
1.2.2 Pharmacovigilance (Pv) Outsourcing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PHARMACOVIGILANCE (PV) OUTSOURCING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pharmacovigilance (Pv) Outsourcing Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Pharmacovigilance (Pv) Outsourcing Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PHARMACOVIGILANCE (PV) OUTSOURCING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Pharmacovigilance (Pv) Outsourcing Product Life Cycle
3.3 Global Pharmacovigilance (Pv) Outsourcing Sales by Manufacturers (2020-2025)
3.4 Global Pharmacovigilance (Pv) Outsourcing Revenue Market Share by Manufacturers (2020-2025)
3.5 Pharmacovigilance (Pv) Outsourcing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pharmacovigilance (Pv) Outsourcing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Pharmacovigilance (Pv) Outsourcing Market Competitive Situation and Trends
3.8.1 Pharmacovigilance (Pv) Outsourcing Market Concentration Rate
3.8.2 Global 5 and 10 Largest Pharmacovigilance (Pv) Outsourcing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PHARMACOVIGILANCE (PV) OUTSOURCING INDUSTRY CHAIN ANALYSIS
4.1 Pharmacovigilance (Pv) Outsourcing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PHARMACOVIGILANCE (PV) OUTSOURCING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Pharmacovigilance (Pv) Outsourcing Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Pharmacovigilance (Pv) Outsourcing Market
5.7 ESG Ratings of Leading Companies
6 PHARMACOVIGILANCE (PV) OUTSOURCING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmacovigilance (Pv) Outsourcing Sales Market Share by Type (2020-2025)
6.3 Global Pharmacovigilance (Pv) Outsourcing Market Size Market Share by Type (2020-2025)
6.4 Global Pharmacovigilance (Pv) Outsourcing Price by Type (2020-2025)
7 PHARMACOVIGILANCE (PV) OUTSOURCING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmacovigilance (Pv) Outsourcing Market Sales by Application (2020-2025)
7.3 Global Pharmacovigilance (Pv) Outsourcing Market Size (M USD) by Application (2020-2025)
7.4 Global Pharmacovigilance (Pv) Outsourcing Sales Growth Rate by Application (2020-2025)
8 PHARMACOVIGILANCE (PV) OUTSOURCING MARKET SALES BY REGION
8.1 Global Pharmacovigilance (Pv) Outsourcing Sales by Region
8.1.1 Global Pharmacovigilance (Pv) Outsourcing Sales by Region
8.1.2 Global Pharmacovigilance (Pv) Outsourcing Sales Market Share by Region
8.2 Global Pharmacovigilance (Pv) Outsourcing Market Size by Region
8.2.1 Global Pharmacovigilance (Pv) Outsourcing Market Size by Region
8.2.2 Global Pharmacovigilance (Pv) Outsourcing Market Size Market Share by Region
8.3 North America
8.3.1 North America Pharmacovigilance (Pv) Outsourcing Sales by Country
8.3.2 North America Pharmacovigilance (Pv) Outsourcing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Pharmacovigilance (Pv) Outsourcing Sales by Country
8.4.2 Europe Pharmacovigilance (Pv) Outsourcing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Pharmacovigilance (Pv) Outsourcing Sales by Region
8.5.2 Asia Pacific Pharmacovigilance (Pv) Outsourcing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Pharmacovigilance (Pv) Outsourcing Sales by Country
8.6.2 South America Pharmacovigilance (Pv) Outsourcing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Pharmacovigilance (Pv) Outsourcing Sales by Region
8.7.2 Middle East and Africa Pharmacovigilance (Pv) Outsourcing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PHARMACOVIGILANCE (PV) OUTSOURCING MARKET PRODUCTION BY REGION
9.1 Global Production of Pharmacovigilance (Pv) Outsourcing by Region(2020-2025)
9.2 Global Pharmacovigilance (Pv) Outsourcing Revenue Market Share by Region (2020-2025)
9.3 Global Pharmacovigilance (Pv) Outsourcing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Pharmacovigilance (Pv) Outsourcing Production
9.4.1 North America Pharmacovigilance (Pv) Outsourcing Production Growth Rate (2020-2025)
9.4.2 North America Pharmacovigilance (Pv) Outsourcing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Pharmacovigilance (Pv) Outsourcing Production
9.5.1 Europe Pharmacovigilance (Pv) Outsourcing Production Growth Rate (2020-2025)
9.5.2 Europe Pharmacovigilance (Pv) Outsourcing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Pharmacovigilance (Pv) Outsourcing Production (2020-2025)
9.6.1 Japan Pharmacovigilance (Pv) Outsourcing Production Growth Rate (2020-2025)
9.6.2 Japan Pharmacovigilance (Pv) Outsourcing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Pharmacovigilance (Pv) Outsourcing Production (2020-2025)
9.7.1 China Pharmacovigilance (Pv) Outsourcing Production Growth Rate (2020-2025)
9.7.2 China Pharmacovigilance (Pv) Outsourcing Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Accenture
10.1.1 Accenture Basic Information
10.1.2 Accenture Pharmacovigilance (Pv) Outsourcing Product Overview
10.1.3 Accenture Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.1.4 Accenture Business Overview
10.1.5 Accenture SWOT Analysis
10.1.6 Accenture Recent Developments
10.2 C3i Solutions
10.2.1 C3i Solutions Basic Information
10.2.2 C3i Solutions Pharmacovigilance (Pv) Outsourcing Product Overview
10.2.3 C3i Solutions Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.2.4 C3i Solutions Business Overview
10.2.5 C3i Solutions SWOT Analysis
10.2.6 C3i Solutions Recent Developments
10.3 Clintec
10.3.1 Clintec Basic Information
10.3.2 Clintec Pharmacovigilance (Pv) Outsourcing Product Overview
10.3.3 Clintec Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.3.4 Clintec Business Overview
10.3.5 Clintec SWOT Analysis
10.3.6 Clintec Recent Developments
10.4 Covance
10.4.1 Covance Basic Information
10.4.2 Covance Pharmacovigilance (Pv) Outsourcing Product Overview
10.4.3 Covance Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.4.4 Covance Business Overview
10.4.5 Covance Recent Developments
10.5 Deloitte Touche Tohmatsu Limited
10.5.1 Deloitte Touche Tohmatsu Limited Basic Information
10.5.2 Deloitte Touche Tohmatsu Limited Pharmacovigilance (Pv) Outsourcing Product Overview
10.5.3 Deloitte Touche Tohmatsu Limited Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.5.4 Deloitte Touche Tohmatsu Limited Business Overview
10.5.5 Deloitte Touche Tohmatsu Limited Recent Developments
10.6 ELC Group
10.6.1 ELC Group Basic Information
10.6.2 ELC Group Pharmacovigilance (Pv) Outsourcing Product Overview
10.6.3 ELC Group Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.6.4 ELC Group Business Overview
10.6.5 ELC Group Recent Developments
10.7 Ergomed
10.7.1 Ergomed Basic Information
10.7.2 Ergomed Pharmacovigilance (Pv) Outsourcing Product Overview
10.7.3 Ergomed Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.7.4 Ergomed Business Overview
10.7.5 Ergomed Recent Developments
10.8 iGATE Corporation
10.8.1 iGATE Corporation Basic Information
10.8.2 iGATE Corporation Pharmacovigilance (Pv) Outsourcing Product Overview
10.8.3 iGATE Corporation Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.8.4 iGATE Corporation Business Overview
10.8.5 iGATE Corporation Recent Developments
10.9 iMED Global Corporation
10.9.1 iMED Global Corporation Basic Information
10.9.2 iMED Global Corporation Pharmacovigilance (Pv) Outsourcing Product Overview
10.9.3 iMED Global Corporation Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.9.4 iMED Global Corporation Business Overview
10.9.5 iMED Global Corporation Recent Developments
10.10 IQVIA
10.10.1 IQVIA Basic Information
10.10.2 IQVIA Pharmacovigilance (Pv) Outsourcing Product Overview
10.10.3 IQVIA Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.10.4 IQVIA Business Overview
10.10.5 IQVIA Recent Developments
10.11 MarksMan Healthcare
10.11.1 MarksMan Healthcare Basic Information
10.11.2 MarksMan Healthcare Pharmacovigilance (Pv) Outsourcing Product Overview
10.11.3 MarksMan Healthcare Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.11.4 MarksMan Healthcare Business Overview
10.11.5 MarksMan Healthcare Recent Developments
10.12 Medpace Holdings
10.12.1 Medpace Holdings Basic Information
10.12.2 Medpace Holdings Pharmacovigilance (Pv) Outsourcing Product Overview
10.12.3 Medpace Holdings Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.12.4 Medpace Holdings Business Overview
10.12.5 Medpace Holdings Recent Developments
10.13 Novartis
10.13.1 Novartis Basic Information
10.13.2 Novartis Pharmacovigilance (Pv) Outsourcing Product Overview
10.13.3 Novartis Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.13.4 Novartis Business Overview
10.13.5 Novartis Recent Developments
10.14 Oracle Corporation
10.14.1 Oracle Corporation Basic Information
10.14.2 Oracle Corporation Pharmacovigilance (Pv) Outsourcing Product Overview
10.14.3 Oracle Corporation Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.14.4 Oracle Corporation Business Overview
10.14.5 Oracle Corporation Recent Developments
10.15 Parexel
10.15.1 Parexel Basic Information
10.15.2 Parexel Pharmacovigilance (Pv) Outsourcing Product Overview
10.15.3 Parexel Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.15.4 Parexel Business Overview
10.15.5 Parexel Recent Developments
10.16 PharmInvent
10.16.1 PharmInvent Basic Information
10.16.2 PharmInvent Pharmacovigilance (Pv) Outsourcing Product Overview
10.16.3 PharmInvent Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.16.4 PharmInvent Business Overview
10.16.5 PharmInvent Recent Developments
10.17 PrimeVigilance
10.17.1 PrimeVigilance Basic Information
10.17.2 PrimeVigilance Pharmacovigilance (Pv) Outsourcing Product Overview
10.17.3 PrimeVigilance Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.17.4 PrimeVigilance Business Overview
10.17.5 PrimeVigilance Recent Developments
10.18 Pure Drug Safety
10.18.1 Pure Drug Safety Basic Information
10.18.2 Pure Drug Safety Pharmacovigilance (Pv) Outsourcing Product Overview
10.18.3 Pure Drug Safety Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.18.4 Pure Drug Safety Business Overview
10.18.5 Pure Drug Safety Recent Developments
10.19 Sciformix
10.19.1 Sciformix Basic Information
10.19.2 Sciformix Pharmacovigilance (Pv) Outsourcing Product Overview
10.19.3 Sciformix Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.19.4 Sciformix Business Overview
10.19.5 Sciformix Recent Developments
10.20 SIRO Clinpharm
10.20.1 SIRO Clinpharm Basic Information
10.20.2 SIRO Clinpharm Pharmacovigilance (Pv) Outsourcing Product Overview
10.20.3 SIRO Clinpharm Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.20.4 SIRO Clinpharm Business Overview
10.20.5 SIRO Clinpharm Recent Developments
10.21 Symogen
10.21.1 Symogen Basic Information
10.21.2 Symogen Pharmacovigilance (Pv) Outsourcing Product Overview
10.21.3 Symogen Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.21.4 Symogen Business Overview
10.21.5 Symogen Recent Developments
11 PHARMACOVIGILANCE (PV) OUTSOURCING MARKET FORECAST BY REGION
11.1 Global Pharmacovigilance (Pv) Outsourcing Market Size Forecast
11.2 Global Pharmacovigilance (Pv) Outsourcing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Pharmacovigilance (Pv) Outsourcing Market Size Forecast by Country
11.2.3 Asia Pacific Pharmacovigilance (Pv) Outsourcing Market Size Forecast by Region
11.2.4 South America Pharmacovigilance (Pv) Outsourcing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Pharmacovigilance (Pv) Outsourcing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Pharmacovigilance (Pv) Outsourcing Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Pharmacovigilance (Pv) Outsourcing by Type (2026-2033)
12.1.2 Global Pharmacovigilance (Pv) Outsourcing Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Pharmacovigilance (Pv) Outsourcing by Type (2026-2033)
12.2 Global Pharmacovigilance (Pv) Outsourcing Market Forecast by Application (2026-2033)
12.2.1 Global Pharmacovigilance (Pv) Outsourcing Sales (K MT) Forecast by Application
12.2.2 Global Pharmacovigilance (Pv) Outsourcing Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Pharmacovigilance (Pv) Outsourcing
1.2 Key Market Segments
1.2.1 Pharmacovigilance (Pv) Outsourcing Segment by Type
1.2.2 Pharmacovigilance (Pv) Outsourcing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PHARMACOVIGILANCE (PV) OUTSOURCING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pharmacovigilance (Pv) Outsourcing Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Pharmacovigilance (Pv) Outsourcing Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PHARMACOVIGILANCE (PV) OUTSOURCING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Pharmacovigilance (Pv) Outsourcing Product Life Cycle
3.3 Global Pharmacovigilance (Pv) Outsourcing Sales by Manufacturers (2020-2025)
3.4 Global Pharmacovigilance (Pv) Outsourcing Revenue Market Share by Manufacturers (2020-2025)
3.5 Pharmacovigilance (Pv) Outsourcing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pharmacovigilance (Pv) Outsourcing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Pharmacovigilance (Pv) Outsourcing Market Competitive Situation and Trends
3.8.1 Pharmacovigilance (Pv) Outsourcing Market Concentration Rate
3.8.2 Global 5 and 10 Largest Pharmacovigilance (Pv) Outsourcing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 PHARMACOVIGILANCE (PV) OUTSOURCING INDUSTRY CHAIN ANALYSIS
4.1 Pharmacovigilance (Pv) Outsourcing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PHARMACOVIGILANCE (PV) OUTSOURCING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Pharmacovigilance (Pv) Outsourcing Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Pharmacovigilance (Pv) Outsourcing Market
5.7 ESG Ratings of Leading Companies
6 PHARMACOVIGILANCE (PV) OUTSOURCING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmacovigilance (Pv) Outsourcing Sales Market Share by Type (2020-2025)
6.3 Global Pharmacovigilance (Pv) Outsourcing Market Size Market Share by Type (2020-2025)
6.4 Global Pharmacovigilance (Pv) Outsourcing Price by Type (2020-2025)
7 PHARMACOVIGILANCE (PV) OUTSOURCING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmacovigilance (Pv) Outsourcing Market Sales by Application (2020-2025)
7.3 Global Pharmacovigilance (Pv) Outsourcing Market Size (M USD) by Application (2020-2025)
7.4 Global Pharmacovigilance (Pv) Outsourcing Sales Growth Rate by Application (2020-2025)
8 PHARMACOVIGILANCE (PV) OUTSOURCING MARKET SALES BY REGION
8.1 Global Pharmacovigilance (Pv) Outsourcing Sales by Region
8.1.1 Global Pharmacovigilance (Pv) Outsourcing Sales by Region
8.1.2 Global Pharmacovigilance (Pv) Outsourcing Sales Market Share by Region
8.2 Global Pharmacovigilance (Pv) Outsourcing Market Size by Region
8.2.1 Global Pharmacovigilance (Pv) Outsourcing Market Size by Region
8.2.2 Global Pharmacovigilance (Pv) Outsourcing Market Size Market Share by Region
8.3 North America
8.3.1 North America Pharmacovigilance (Pv) Outsourcing Sales by Country
8.3.2 North America Pharmacovigilance (Pv) Outsourcing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Pharmacovigilance (Pv) Outsourcing Sales by Country
8.4.2 Europe Pharmacovigilance (Pv) Outsourcing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Pharmacovigilance (Pv) Outsourcing Sales by Region
8.5.2 Asia Pacific Pharmacovigilance (Pv) Outsourcing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Pharmacovigilance (Pv) Outsourcing Sales by Country
8.6.2 South America Pharmacovigilance (Pv) Outsourcing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Pharmacovigilance (Pv) Outsourcing Sales by Region
8.7.2 Middle East and Africa Pharmacovigilance (Pv) Outsourcing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 PHARMACOVIGILANCE (PV) OUTSOURCING MARKET PRODUCTION BY REGION
9.1 Global Production of Pharmacovigilance (Pv) Outsourcing by Region(2020-2025)
9.2 Global Pharmacovigilance (Pv) Outsourcing Revenue Market Share by Region (2020-2025)
9.3 Global Pharmacovigilance (Pv) Outsourcing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Pharmacovigilance (Pv) Outsourcing Production
9.4.1 North America Pharmacovigilance (Pv) Outsourcing Production Growth Rate (2020-2025)
9.4.2 North America Pharmacovigilance (Pv) Outsourcing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Pharmacovigilance (Pv) Outsourcing Production
9.5.1 Europe Pharmacovigilance (Pv) Outsourcing Production Growth Rate (2020-2025)
9.5.2 Europe Pharmacovigilance (Pv) Outsourcing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Pharmacovigilance (Pv) Outsourcing Production (2020-2025)
9.6.1 Japan Pharmacovigilance (Pv) Outsourcing Production Growth Rate (2020-2025)
9.6.2 Japan Pharmacovigilance (Pv) Outsourcing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Pharmacovigilance (Pv) Outsourcing Production (2020-2025)
9.7.1 China Pharmacovigilance (Pv) Outsourcing Production Growth Rate (2020-2025)
9.7.2 China Pharmacovigilance (Pv) Outsourcing Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Accenture
10.1.1 Accenture Basic Information
10.1.2 Accenture Pharmacovigilance (Pv) Outsourcing Product Overview
10.1.3 Accenture Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.1.4 Accenture Business Overview
10.1.5 Accenture SWOT Analysis
10.1.6 Accenture Recent Developments
10.2 C3i Solutions
10.2.1 C3i Solutions Basic Information
10.2.2 C3i Solutions Pharmacovigilance (Pv) Outsourcing Product Overview
10.2.3 C3i Solutions Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.2.4 C3i Solutions Business Overview
10.2.5 C3i Solutions SWOT Analysis
10.2.6 C3i Solutions Recent Developments
10.3 Clintec
10.3.1 Clintec Basic Information
10.3.2 Clintec Pharmacovigilance (Pv) Outsourcing Product Overview
10.3.3 Clintec Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.3.4 Clintec Business Overview
10.3.5 Clintec SWOT Analysis
10.3.6 Clintec Recent Developments
10.4 Covance
10.4.1 Covance Basic Information
10.4.2 Covance Pharmacovigilance (Pv) Outsourcing Product Overview
10.4.3 Covance Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.4.4 Covance Business Overview
10.4.5 Covance Recent Developments
10.5 Deloitte Touche Tohmatsu Limited
10.5.1 Deloitte Touche Tohmatsu Limited Basic Information
10.5.2 Deloitte Touche Tohmatsu Limited Pharmacovigilance (Pv) Outsourcing Product Overview
10.5.3 Deloitte Touche Tohmatsu Limited Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.5.4 Deloitte Touche Tohmatsu Limited Business Overview
10.5.5 Deloitte Touche Tohmatsu Limited Recent Developments
10.6 ELC Group
10.6.1 ELC Group Basic Information
10.6.2 ELC Group Pharmacovigilance (Pv) Outsourcing Product Overview
10.6.3 ELC Group Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.6.4 ELC Group Business Overview
10.6.5 ELC Group Recent Developments
10.7 Ergomed
10.7.1 Ergomed Basic Information
10.7.2 Ergomed Pharmacovigilance (Pv) Outsourcing Product Overview
10.7.3 Ergomed Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.7.4 Ergomed Business Overview
10.7.5 Ergomed Recent Developments
10.8 iGATE Corporation
10.8.1 iGATE Corporation Basic Information
10.8.2 iGATE Corporation Pharmacovigilance (Pv) Outsourcing Product Overview
10.8.3 iGATE Corporation Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.8.4 iGATE Corporation Business Overview
10.8.5 iGATE Corporation Recent Developments
10.9 iMED Global Corporation
10.9.1 iMED Global Corporation Basic Information
10.9.2 iMED Global Corporation Pharmacovigilance (Pv) Outsourcing Product Overview
10.9.3 iMED Global Corporation Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.9.4 iMED Global Corporation Business Overview
10.9.5 iMED Global Corporation Recent Developments
10.10 IQVIA
10.10.1 IQVIA Basic Information
10.10.2 IQVIA Pharmacovigilance (Pv) Outsourcing Product Overview
10.10.3 IQVIA Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.10.4 IQVIA Business Overview
10.10.5 IQVIA Recent Developments
10.11 MarksMan Healthcare
10.11.1 MarksMan Healthcare Basic Information
10.11.2 MarksMan Healthcare Pharmacovigilance (Pv) Outsourcing Product Overview
10.11.3 MarksMan Healthcare Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.11.4 MarksMan Healthcare Business Overview
10.11.5 MarksMan Healthcare Recent Developments
10.12 Medpace Holdings
10.12.1 Medpace Holdings Basic Information
10.12.2 Medpace Holdings Pharmacovigilance (Pv) Outsourcing Product Overview
10.12.3 Medpace Holdings Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.12.4 Medpace Holdings Business Overview
10.12.5 Medpace Holdings Recent Developments
10.13 Novartis
10.13.1 Novartis Basic Information
10.13.2 Novartis Pharmacovigilance (Pv) Outsourcing Product Overview
10.13.3 Novartis Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.13.4 Novartis Business Overview
10.13.5 Novartis Recent Developments
10.14 Oracle Corporation
10.14.1 Oracle Corporation Basic Information
10.14.2 Oracle Corporation Pharmacovigilance (Pv) Outsourcing Product Overview
10.14.3 Oracle Corporation Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.14.4 Oracle Corporation Business Overview
10.14.5 Oracle Corporation Recent Developments
10.15 Parexel
10.15.1 Parexel Basic Information
10.15.2 Parexel Pharmacovigilance (Pv) Outsourcing Product Overview
10.15.3 Parexel Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.15.4 Parexel Business Overview
10.15.5 Parexel Recent Developments
10.16 PharmInvent
10.16.1 PharmInvent Basic Information
10.16.2 PharmInvent Pharmacovigilance (Pv) Outsourcing Product Overview
10.16.3 PharmInvent Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.16.4 PharmInvent Business Overview
10.16.5 PharmInvent Recent Developments
10.17 PrimeVigilance
10.17.1 PrimeVigilance Basic Information
10.17.2 PrimeVigilance Pharmacovigilance (Pv) Outsourcing Product Overview
10.17.3 PrimeVigilance Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.17.4 PrimeVigilance Business Overview
10.17.5 PrimeVigilance Recent Developments
10.18 Pure Drug Safety
10.18.1 Pure Drug Safety Basic Information
10.18.2 Pure Drug Safety Pharmacovigilance (Pv) Outsourcing Product Overview
10.18.3 Pure Drug Safety Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.18.4 Pure Drug Safety Business Overview
10.18.5 Pure Drug Safety Recent Developments
10.19 Sciformix
10.19.1 Sciformix Basic Information
10.19.2 Sciformix Pharmacovigilance (Pv) Outsourcing Product Overview
10.19.3 Sciformix Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.19.4 Sciformix Business Overview
10.19.5 Sciformix Recent Developments
10.20 SIRO Clinpharm
10.20.1 SIRO Clinpharm Basic Information
10.20.2 SIRO Clinpharm Pharmacovigilance (Pv) Outsourcing Product Overview
10.20.3 SIRO Clinpharm Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.20.4 SIRO Clinpharm Business Overview
10.20.5 SIRO Clinpharm Recent Developments
10.21 Symogen
10.21.1 Symogen Basic Information
10.21.2 Symogen Pharmacovigilance (Pv) Outsourcing Product Overview
10.21.3 Symogen Pharmacovigilance (Pv) Outsourcing Product Market Performance
10.21.4 Symogen Business Overview
10.21.5 Symogen Recent Developments
11 PHARMACOVIGILANCE (PV) OUTSOURCING MARKET FORECAST BY REGION
11.1 Global Pharmacovigilance (Pv) Outsourcing Market Size Forecast
11.2 Global Pharmacovigilance (Pv) Outsourcing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Pharmacovigilance (Pv) Outsourcing Market Size Forecast by Country
11.2.3 Asia Pacific Pharmacovigilance (Pv) Outsourcing Market Size Forecast by Region
11.2.4 South America Pharmacovigilance (Pv) Outsourcing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Pharmacovigilance (Pv) Outsourcing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Pharmacovigilance (Pv) Outsourcing Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Pharmacovigilance (Pv) Outsourcing by Type (2026-2033)
12.1.2 Global Pharmacovigilance (Pv) Outsourcing Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Pharmacovigilance (Pv) Outsourcing by Type (2026-2033)
12.2 Global Pharmacovigilance (Pv) Outsourcing Market Forecast by Application (2026-2033)
12.2.1 Global Pharmacovigilance (Pv) Outsourcing Sales (K MT) Forecast by Application
12.2.2 Global Pharmacovigilance (Pv) Outsourcing Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pharmacovigilance (Pv) Outsourcing Market Size Comparison by Region (M USD)
Table 5. Global Pharmacovigilance (Pv) Outsourcing Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Pharmacovigilance (Pv) Outsourcing Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Pharmacovigilance (Pv) Outsourcing Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Pharmacovigilance (Pv) Outsourcing Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance (Pv) Outsourcing as of 2024)
Table 10. Global Market Pharmacovigilance (Pv) Outsourcing Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Pharmacovigilance (Pv) Outsourcing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Pharmacovigilance (Pv) Outsourcing Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Pharmacovigilance (Pv) Outsourcing Sales by Type (K MT)
Table 26. Global Pharmacovigilance (Pv) Outsourcing Market Size by Type (M USD)
Table 27. Global Pharmacovigilance (Pv) Outsourcing Sales (K MT) by Type (2020-2025)
Table 28. Global Pharmacovigilance (Pv) Outsourcing Sales Market Share by Type (2020-2025)
Table 29. Global Pharmacovigilance (Pv) Outsourcing Market Size (M USD) by Type (2020-2025)
Table 30. Global Pharmacovigilance (Pv) Outsourcing Market Size Share by Type (2020-2025)
Table 31. Global Pharmacovigilance (Pv) Outsourcing Price (USD/KG) by Type (2020-2025)
Table 32. Global Pharmacovigilance (Pv) Outsourcing Sales (K MT) by Application
Table 33. Global Pharmacovigilance (Pv) Outsourcing Market Size by Application
Table 34. Global Pharmacovigilance (Pv) Outsourcing Sales by Application (2020-2025) & (K MT)
Table 35. Global Pharmacovigilance (Pv) Outsourcing Sales Market Share by Application (2020-2025)
Table 36. Global Pharmacovigilance (Pv) Outsourcing Market Size by Application (2020-2025) & (M USD)
Table 37. Global Pharmacovigilance (Pv) Outsourcing Market Share by Application (2020-2025)
Table 38. Global Pharmacovigilance (Pv) Outsourcing Sales Growth Rate by Application (2020-2025)
Table 39. Global Pharmacovigilance (Pv) Outsourcing Sales by Region (2020-2025) & (K MT)
Table 40. Global Pharmacovigilance (Pv) Outsourcing Sales Market Share by Region (2020-2025)
Table 41. Global Pharmacovigilance (Pv) Outsourcing Market Size by Region (2020-2025) & (M USD)
Table 42. Global Pharmacovigilance (Pv) Outsourcing Market Size Market Share by Region (2020-2025)
Table 43. North America Pharmacovigilance (Pv) Outsourcing Sales by Country (2020-2025) & (K MT)
Table 44. North America Pharmacovigilance (Pv) Outsourcing Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Pharmacovigilance (Pv) Outsourcing Sales by Country (2020-2025) & (K MT)
Table 46. Europe Pharmacovigilance (Pv) Outsourcing Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Pharmacovigilance (Pv) Outsourcing Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Pharmacovigilance (Pv) Outsourcing Market Size by Region (2020-2025) & (M USD)
Table 49. South America Pharmacovigilance (Pv) Outsourcing Sales by Country (2020-2025) & (K MT)
Table 50. South America Pharmacovigilance (Pv) Outsourcing Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Pharmacovigilance (Pv) Outsourcing Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Pharmacovigilance (Pv) Outsourcing Market Size by Region (2020-2025) & (M USD)
Table 53. Global Pharmacovigilance (Pv) Outsourcing Production (K MT) by Region(2020-2025)
Table 54. Global Pharmacovigilance (Pv) Outsourcing Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Pharmacovigilance (Pv) Outsourcing Revenue Market Share by Region (2020-2025)
Table 56. Global Pharmacovigilance (Pv) Outsourcing Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Pharmacovigilance (Pv) Outsourcing Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Pharmacovigilance (Pv) Outsourcing Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Pharmacovigilance (Pv) Outsourcing Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Pharmacovigilance (Pv) Outsourcing Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Accenture Basic Information
Table 62. Accenture Pharmacovigilance (Pv) Outsourcing Product Overview
Table 63. Accenture Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Accenture Business Overview
Table 65. Accenture SWOT Analysis
Table 66. Accenture Recent Developments
Table 67. C3i Solutions Basic Information
Table 68. C3i Solutions Pharmacovigilance (Pv) Outsourcing Product Overview
Table 69. C3i Solutions Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. C3i Solutions Business Overview
Table 71. C3i Solutions SWOT Analysis
Table 72. C3i Solutions Recent Developments
Table 73. Clintec Basic Information
Table 74. Clintec Pharmacovigilance (Pv) Outsourcing Product Overview
Table 75. Clintec Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Clintec Business Overview
Table 77. Clintec SWOT Analysis
Table 78. Clintec Recent Developments
Table 79. Covance Basic Information
Table 80. Covance Pharmacovigilance (Pv) Outsourcing Product Overview
Table 81. Covance Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Covance Business Overview
Table 83. Covance Recent Developments
Table 84. Deloitte Touche Tohmatsu Limited Basic Information
Table 85. Deloitte Touche Tohmatsu Limited Pharmacovigilance (Pv) Outsourcing Product Overview
Table 86. Deloitte Touche Tohmatsu Limited Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Deloitte Touche Tohmatsu Limited Business Overview
Table 88. Deloitte Touche Tohmatsu Limited Recent Developments
Table 89. ELC Group Basic Information
Table 90. ELC Group Pharmacovigilance (Pv) Outsourcing Product Overview
Table 91. ELC Group Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. ELC Group Business Overview
Table 93. ELC Group Recent Developments
Table 94. Ergomed Basic Information
Table 95. Ergomed Pharmacovigilance (Pv) Outsourcing Product Overview
Table 96. Ergomed Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Ergomed Business Overview
Table 98. Ergomed Recent Developments
Table 99. iGATE Corporation Basic Information
Table 100. iGATE Corporation Pharmacovigilance (Pv) Outsourcing Product Overview
Table 101. iGATE Corporation Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. iGATE Corporation Business Overview
Table 103. iGATE Corporation Recent Developments
Table 104. iMED Global Corporation Basic Information
Table 105. iMED Global Corporation Pharmacovigilance (Pv) Outsourcing Product Overview
Table 106. iMED Global Corporation Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. iMED Global Corporation Business Overview
Table 108. iMED Global Corporation Recent Developments
Table 109. IQVIA Basic Information
Table 110. IQVIA Pharmacovigilance (Pv) Outsourcing Product Overview
Table 111. IQVIA Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. IQVIA Business Overview
Table 113. IQVIA Recent Developments
Table 114. MarksMan Healthcare Basic Information
Table 115. MarksMan Healthcare Pharmacovigilance (Pv) Outsourcing Product Overview
Table 116. MarksMan Healthcare Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. MarksMan Healthcare Business Overview
Table 118. MarksMan Healthcare Recent Developments
Table 119. Medpace Holdings Basic Information
Table 120. Medpace Holdings Pharmacovigilance (Pv) Outsourcing Product Overview
Table 121. Medpace Holdings Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Medpace Holdings Business Overview
Table 123. Medpace Holdings Recent Developments
Table 124. Novartis Basic Information
Table 125. Novartis Pharmacovigilance (Pv) Outsourcing Product Overview
Table 126. Novartis Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. Novartis Business Overview
Table 128. Novartis Recent Developments
Table 129. Oracle Corporation Basic Information
Table 130. Oracle Corporation Pharmacovigilance (Pv) Outsourcing Product Overview
Table 131. Oracle Corporation Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 132. Oracle Corporation Business Overview
Table 133. Oracle Corporation Recent Developments
Table 134. Parexel Basic Information
Table 135. Parexel Pharmacovigilance (Pv) Outsourcing Product Overview
Table 136. Parexel Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 137. Parexel Business Overview
Table 138. Parexel Recent Developments
Table 139. PharmInvent Basic Information
Table 140. PharmInvent Pharmacovigilance (Pv) Outsourcing Product Overview
Table 141. PharmInvent Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 142. PharmInvent Business Overview
Table 143. PharmInvent Recent Developments
Table 144. PrimeVigilance Basic Information
Table 145. PrimeVigilance Pharmacovigilance (Pv) Outsourcing Product Overview
Table 146. PrimeVigilance Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 147. PrimeVigilance Business Overview
Table 148. PrimeVigilance Recent Developments
Table 149. Pure Drug Safety Basic Information
Table 150. Pure Drug Safety Pharmacovigilance (Pv) Outsourcing Product Overview
Table 151. Pure Drug Safety Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 152. Pure Drug Safety Business Overview
Table 153. Pure Drug Safety Recent Developments
Table 154. Sciformix Basic Information
Table 155. Sciformix Pharmacovigilance (Pv) Outsourcing Product Overview
Table 156. Sciformix Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 157. Sciformix Business Overview
Table 158. Sciformix Recent Developments
Table 159. SIRO Clinpharm Basic Information
Table 160. SIRO Clinpharm Pharmacovigilance (Pv) Outsourcing Product Overview
Table 161. SIRO Clinpharm Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 162. SIRO Clinpharm Business Overview
Table 163. SIRO Clinpharm Recent Developments
Table 164. Symogen Basic Information
Table 165. Symogen Pharmacovigilance (Pv) Outsourcing Product Overview
Table 166. Symogen Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 167. Symogen Business Overview
Table 168. Symogen Recent Developments
Table 169. Global Pharmacovigilance (Pv) Outsourcing Sales Forecast by Region (2026-2033) & (K MT)
Table 170. Global Pharmacovigilance (Pv) Outsourcing Market Size Forecast by Region (2026-2033) & (M USD)
Table 171. North America Pharmacovigilance (Pv) Outsourcing Sales Forecast by Country (2026-2033) & (K MT)
Table 172. North America Pharmacovigilance (Pv) Outsourcing Market Size Forecast by Country (2026-2033) & (M USD)
Table 173. Europe Pharmacovigilance (Pv) Outsourcing Sales Forecast by Country (2026-2033) & (K MT)
Table 174. Europe Pharmacovigilance (Pv) Outsourcing Market Size Forecast by Country (2026-2033) & (M USD)
Table 175. Asia Pacific Pharmacovigilance (Pv) Outsourcing Sales Forecast by Region (2026-2033) & (K MT)
Table 176. Asia Pacific Pharmacovigilance (Pv) Outsourcing Market Size Forecast by Region (2026-2033) & (M USD)
Table 177. South America Pharmacovigilance (Pv) Outsourcing Sales Forecast by Country (2026-2033) & (K MT)
Table 178. South America Pharmacovigilance (Pv) Outsourcing Market Size Forecast by Country (2026-2033) & (M USD)
Table 179. Middle East and Africa Pharmacovigilance (Pv) Outsourcing Sales Forecast by Country (2026-2033) & (Units)
Table 180. Middle East and Africa Pharmacovigilance (Pv) Outsourcing Market Size Forecast by Country (2026-2033) & (M USD)
Table 181. Global Pharmacovigilance (Pv) Outsourcing Sales Forecast by Type (2026-2033) & (K MT)
Table 182. Global Pharmacovigilance (Pv) Outsourcing Market Size Forecast by Type (2026-2033) & (M USD)
Table 183. Global Pharmacovigilance (Pv) Outsourcing Price Forecast by Type (2026-2033) & (USD/KG)
Table 184. Global Pharmacovigilance (Pv) Outsourcing Sales (K MT) Forecast by Application (2026-2033)
Table 185. Global Pharmacovigilance (Pv) Outsourcing Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pharmacovigilance (Pv) Outsourcing Market Size Comparison by Region (M USD)
Table 5. Global Pharmacovigilance (Pv) Outsourcing Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Pharmacovigilance (Pv) Outsourcing Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Pharmacovigilance (Pv) Outsourcing Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Pharmacovigilance (Pv) Outsourcing Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance (Pv) Outsourcing as of 2024)
Table 10. Global Market Pharmacovigilance (Pv) Outsourcing Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Pharmacovigilance (Pv) Outsourcing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Pharmacovigilance (Pv) Outsourcing Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Pharmacovigilance (Pv) Outsourcing Sales by Type (K MT)
Table 26. Global Pharmacovigilance (Pv) Outsourcing Market Size by Type (M USD)
Table 27. Global Pharmacovigilance (Pv) Outsourcing Sales (K MT) by Type (2020-2025)
Table 28. Global Pharmacovigilance (Pv) Outsourcing Sales Market Share by Type (2020-2025)
Table 29. Global Pharmacovigilance (Pv) Outsourcing Market Size (M USD) by Type (2020-2025)
Table 30. Global Pharmacovigilance (Pv) Outsourcing Market Size Share by Type (2020-2025)
Table 31. Global Pharmacovigilance (Pv) Outsourcing Price (USD/KG) by Type (2020-2025)
Table 32. Global Pharmacovigilance (Pv) Outsourcing Sales (K MT) by Application
Table 33. Global Pharmacovigilance (Pv) Outsourcing Market Size by Application
Table 34. Global Pharmacovigilance (Pv) Outsourcing Sales by Application (2020-2025) & (K MT)
Table 35. Global Pharmacovigilance (Pv) Outsourcing Sales Market Share by Application (2020-2025)
Table 36. Global Pharmacovigilance (Pv) Outsourcing Market Size by Application (2020-2025) & (M USD)
Table 37. Global Pharmacovigilance (Pv) Outsourcing Market Share by Application (2020-2025)
Table 38. Global Pharmacovigilance (Pv) Outsourcing Sales Growth Rate by Application (2020-2025)
Table 39. Global Pharmacovigilance (Pv) Outsourcing Sales by Region (2020-2025) & (K MT)
Table 40. Global Pharmacovigilance (Pv) Outsourcing Sales Market Share by Region (2020-2025)
Table 41. Global Pharmacovigilance (Pv) Outsourcing Market Size by Region (2020-2025) & (M USD)
Table 42. Global Pharmacovigilance (Pv) Outsourcing Market Size Market Share by Region (2020-2025)
Table 43. North America Pharmacovigilance (Pv) Outsourcing Sales by Country (2020-2025) & (K MT)
Table 44. North America Pharmacovigilance (Pv) Outsourcing Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Pharmacovigilance (Pv) Outsourcing Sales by Country (2020-2025) & (K MT)
Table 46. Europe Pharmacovigilance (Pv) Outsourcing Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Pharmacovigilance (Pv) Outsourcing Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Pharmacovigilance (Pv) Outsourcing Market Size by Region (2020-2025) & (M USD)
Table 49. South America Pharmacovigilance (Pv) Outsourcing Sales by Country (2020-2025) & (K MT)
Table 50. South America Pharmacovigilance (Pv) Outsourcing Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Pharmacovigilance (Pv) Outsourcing Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Pharmacovigilance (Pv) Outsourcing Market Size by Region (2020-2025) & (M USD)
Table 53. Global Pharmacovigilance (Pv) Outsourcing Production (K MT) by Region(2020-2025)
Table 54. Global Pharmacovigilance (Pv) Outsourcing Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Pharmacovigilance (Pv) Outsourcing Revenue Market Share by Region (2020-2025)
Table 56. Global Pharmacovigilance (Pv) Outsourcing Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Pharmacovigilance (Pv) Outsourcing Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Pharmacovigilance (Pv) Outsourcing Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Pharmacovigilance (Pv) Outsourcing Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Pharmacovigilance (Pv) Outsourcing Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Accenture Basic Information
Table 62. Accenture Pharmacovigilance (Pv) Outsourcing Product Overview
Table 63. Accenture Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Accenture Business Overview
Table 65. Accenture SWOT Analysis
Table 66. Accenture Recent Developments
Table 67. C3i Solutions Basic Information
Table 68. C3i Solutions Pharmacovigilance (Pv) Outsourcing Product Overview
Table 69. C3i Solutions Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. C3i Solutions Business Overview
Table 71. C3i Solutions SWOT Analysis
Table 72. C3i Solutions Recent Developments
Table 73. Clintec Basic Information
Table 74. Clintec Pharmacovigilance (Pv) Outsourcing Product Overview
Table 75. Clintec Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Clintec Business Overview
Table 77. Clintec SWOT Analysis
Table 78. Clintec Recent Developments
Table 79. Covance Basic Information
Table 80. Covance Pharmacovigilance (Pv) Outsourcing Product Overview
Table 81. Covance Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Covance Business Overview
Table 83. Covance Recent Developments
Table 84. Deloitte Touche Tohmatsu Limited Basic Information
Table 85. Deloitte Touche Tohmatsu Limited Pharmacovigilance (Pv) Outsourcing Product Overview
Table 86. Deloitte Touche Tohmatsu Limited Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Deloitte Touche Tohmatsu Limited Business Overview
Table 88. Deloitte Touche Tohmatsu Limited Recent Developments
Table 89. ELC Group Basic Information
Table 90. ELC Group Pharmacovigilance (Pv) Outsourcing Product Overview
Table 91. ELC Group Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. ELC Group Business Overview
Table 93. ELC Group Recent Developments
Table 94. Ergomed Basic Information
Table 95. Ergomed Pharmacovigilance (Pv) Outsourcing Product Overview
Table 96. Ergomed Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Ergomed Business Overview
Table 98. Ergomed Recent Developments
Table 99. iGATE Corporation Basic Information
Table 100. iGATE Corporation Pharmacovigilance (Pv) Outsourcing Product Overview
Table 101. iGATE Corporation Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. iGATE Corporation Business Overview
Table 103. iGATE Corporation Recent Developments
Table 104. iMED Global Corporation Basic Information
Table 105. iMED Global Corporation Pharmacovigilance (Pv) Outsourcing Product Overview
Table 106. iMED Global Corporation Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. iMED Global Corporation Business Overview
Table 108. iMED Global Corporation Recent Developments
Table 109. IQVIA Basic Information
Table 110. IQVIA Pharmacovigilance (Pv) Outsourcing Product Overview
Table 111. IQVIA Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. IQVIA Business Overview
Table 113. IQVIA Recent Developments
Table 114. MarksMan Healthcare Basic Information
Table 115. MarksMan Healthcare Pharmacovigilance (Pv) Outsourcing Product Overview
Table 116. MarksMan Healthcare Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. MarksMan Healthcare Business Overview
Table 118. MarksMan Healthcare Recent Developments
Table 119. Medpace Holdings Basic Information
Table 120. Medpace Holdings Pharmacovigilance (Pv) Outsourcing Product Overview
Table 121. Medpace Holdings Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Medpace Holdings Business Overview
Table 123. Medpace Holdings Recent Developments
Table 124. Novartis Basic Information
Table 125. Novartis Pharmacovigilance (Pv) Outsourcing Product Overview
Table 126. Novartis Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. Novartis Business Overview
Table 128. Novartis Recent Developments
Table 129. Oracle Corporation Basic Information
Table 130. Oracle Corporation Pharmacovigilance (Pv) Outsourcing Product Overview
Table 131. Oracle Corporation Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 132. Oracle Corporation Business Overview
Table 133. Oracle Corporation Recent Developments
Table 134. Parexel Basic Information
Table 135. Parexel Pharmacovigilance (Pv) Outsourcing Product Overview
Table 136. Parexel Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 137. Parexel Business Overview
Table 138. Parexel Recent Developments
Table 139. PharmInvent Basic Information
Table 140. PharmInvent Pharmacovigilance (Pv) Outsourcing Product Overview
Table 141. PharmInvent Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 142. PharmInvent Business Overview
Table 143. PharmInvent Recent Developments
Table 144. PrimeVigilance Basic Information
Table 145. PrimeVigilance Pharmacovigilance (Pv) Outsourcing Product Overview
Table 146. PrimeVigilance Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 147. PrimeVigilance Business Overview
Table 148. PrimeVigilance Recent Developments
Table 149. Pure Drug Safety Basic Information
Table 150. Pure Drug Safety Pharmacovigilance (Pv) Outsourcing Product Overview
Table 151. Pure Drug Safety Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 152. Pure Drug Safety Business Overview
Table 153. Pure Drug Safety Recent Developments
Table 154. Sciformix Basic Information
Table 155. Sciformix Pharmacovigilance (Pv) Outsourcing Product Overview
Table 156. Sciformix Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 157. Sciformix Business Overview
Table 158. Sciformix Recent Developments
Table 159. SIRO Clinpharm Basic Information
Table 160. SIRO Clinpharm Pharmacovigilance (Pv) Outsourcing Product Overview
Table 161. SIRO Clinpharm Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 162. SIRO Clinpharm Business Overview
Table 163. SIRO Clinpharm Recent Developments
Table 164. Symogen Basic Information
Table 165. Symogen Pharmacovigilance (Pv) Outsourcing Product Overview
Table 166. Symogen Pharmacovigilance (Pv) Outsourcing Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 167. Symogen Business Overview
Table 168. Symogen Recent Developments
Table 169. Global Pharmacovigilance (Pv) Outsourcing Sales Forecast by Region (2026-2033) & (K MT)
Table 170. Global Pharmacovigilance (Pv) Outsourcing Market Size Forecast by Region (2026-2033) & (M USD)
Table 171. North America Pharmacovigilance (Pv) Outsourcing Sales Forecast by Country (2026-2033) & (K MT)
Table 172. North America Pharmacovigilance (Pv) Outsourcing Market Size Forecast by Country (2026-2033) & (M USD)
Table 173. Europe Pharmacovigilance (Pv) Outsourcing Sales Forecast by Country (2026-2033) & (K MT)
Table 174. Europe Pharmacovigilance (Pv) Outsourcing Market Size Forecast by Country (2026-2033) & (M USD)
Table 175. Asia Pacific Pharmacovigilance (Pv) Outsourcing Sales Forecast by Region (2026-2033) & (K MT)
Table 176. Asia Pacific Pharmacovigilance (Pv) Outsourcing Market Size Forecast by Region (2026-2033) & (M USD)
Table 177. South America Pharmacovigilance (Pv) Outsourcing Sales Forecast by Country (2026-2033) & (K MT)
Table 178. South America Pharmacovigilance (Pv) Outsourcing Market Size Forecast by Country (2026-2033) & (M USD)
Table 179. Middle East and Africa Pharmacovigilance (Pv) Outsourcing Sales Forecast by Country (2026-2033) & (Units)
Table 180. Middle East and Africa Pharmacovigilance (Pv) Outsourcing Market Size Forecast by Country (2026-2033) & (M USD)
Table 181. Global Pharmacovigilance (Pv) Outsourcing Sales Forecast by Type (2026-2033) & (K MT)
Table 182. Global Pharmacovigilance (Pv) Outsourcing Market Size Forecast by Type (2026-2033) & (M USD)
Table 183. Global Pharmacovigilance (Pv) Outsourcing Price Forecast by Type (2026-2033) & (USD/KG)
Table 184. Global Pharmacovigilance (Pv) Outsourcing Sales (K MT) Forecast by Application (2026-2033)
Table 185. Global Pharmacovigilance (Pv) Outsourcing Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Pharmacovigilance (Pv) Outsourcing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pharmacovigilance (Pv) Outsourcing Market Size (M USD), 2024-2033
Figure 5. Global Pharmacovigilance (Pv) Outsourcing Market Size (M USD) (2020-2033)
Figure 6. Global Pharmacovigilance (Pv) Outsourcing Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pharmacovigilance (Pv) Outsourcing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pharmacovigilance (Pv) Outsourcing Product Life Cycle
Figure 13. Pharmacovigilance (Pv) Outsourcing Sales Share by Manufacturers in 2024
Figure 14. Global Pharmacovigilance (Pv) Outsourcing Revenue Share by Manufacturers in 2024
Figure 15. Pharmacovigilance (Pv) Outsourcing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Pharmacovigilance (Pv) Outsourcing Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pharmacovigilance (Pv) Outsourcing Revenue in 2024
Figure 18. Industry Chain Map of Pharmacovigilance (Pv) Outsourcing
Figure 19. Global Pharmacovigilance (Pv) Outsourcing Market PEST Analysis
Figure 20. Global Pharmacovigilance (Pv) Outsourcing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Pharmacovigilance (Pv) Outsourcing Market Share by Type
Figure 27. Sales Market Share of Pharmacovigilance (Pv) Outsourcing by Type (2020-2025)
Figure 28. Sales Market Share of Pharmacovigilance (Pv) Outsourcing by Type in 2024
Figure 29. Market Size Share of Pharmacovigilance (Pv) Outsourcing by Type (2020-2025)
Figure 30. Market Size Share of Pharmacovigilance (Pv) Outsourcing by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Pharmacovigilance (Pv) Outsourcing Market Share by Application
Figure 33. Global Pharmacovigilance (Pv) Outsourcing Sales Market Share by Application (2020-2025)
Figure 34. Global Pharmacovigilance (Pv) Outsourcing Sales Market Share by Application in 2024
Figure 35. Global Pharmacovigilance (Pv) Outsourcing Market Share by Application (2020-2025)
Figure 36. Global Pharmacovigilance (Pv) Outsourcing Market Share by Application in 2024
Figure 37. Global Pharmacovigilance (Pv) Outsourcing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Pharmacovigilance (Pv) Outsourcing Sales Market Share by Region (2020-2025)
Figure 39. Global Pharmacovigilance (Pv) Outsourcing Market Size Market Share by Region (2020-2025)
Figure 40. North America Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Pharmacovigilance (Pv) Outsourcing Sales Market Share by Country in 2024
Figure 43. North America Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Pharmacovigilance (Pv) Outsourcing Market Size Market Share by Country in 2024
Figure 45. U.S. Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Pharmacovigilance (Pv) Outsourcing Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Pharmacovigilance (Pv) Outsourcing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Pharmacovigilance (Pv) Outsourcing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Pharmacovigilance (Pv) Outsourcing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Pharmacovigilance (Pv) Outsourcing Sales Market Share by Country in 2024
Figure 53. Europe Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Pharmacovigilance (Pv) Outsourcing Market Size Market Share by Country in 2024
Figure 55. Germany Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Pharmacovigilance (Pv) Outsourcing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Pharmacovigilance (Pv) Outsourcing Market Size Market Share by Region in 2024
Figure 68. China Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (K MT)
Figure 79. South America Pharmacovigilance (Pv) Outsourcing Sales Market Share by Country in 2024
Figure 80. South America Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (M USD)
Figure 81. South America Pharmacovigilance (Pv) Outsourcing Market Size Market Share by Country in 2024
Figure 82. Brazil Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Pharmacovigilance (Pv) Outsourcing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Pharmacovigilance (Pv) Outsourcing Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Pharmacovigilance (Pv) Outsourcing Production Market Share by Region (2020-2025)
Figure 103. North America Pharmacovigilance (Pv) Outsourcing Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Pharmacovigilance (Pv) Outsourcing Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Pharmacovigilance (Pv) Outsourcing Production (K MT) Growth Rate (2020-2025)
Figure 106. China Pharmacovigilance (Pv) Outsourcing Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Pharmacovigilance (Pv) Outsourcing Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Pharmacovigilance (Pv) Outsourcing Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Pharmacovigilance (Pv) Outsourcing Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Pharmacovigilance (Pv) Outsourcing Market Share Forecast by Type (2026-2033)
Figure 111. Global Pharmacovigilance (Pv) Outsourcing Sales Forecast by Application (2026-2033)
Figure 112. Global Pharmacovigilance (Pv) Outsourcing Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Pharmacovigilance (Pv) Outsourcing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pharmacovigilance (Pv) Outsourcing Market Size (M USD), 2024-2033
Figure 5. Global Pharmacovigilance (Pv) Outsourcing Market Size (M USD) (2020-2033)
Figure 6. Global Pharmacovigilance (Pv) Outsourcing Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pharmacovigilance (Pv) Outsourcing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pharmacovigilance (Pv) Outsourcing Product Life Cycle
Figure 13. Pharmacovigilance (Pv) Outsourcing Sales Share by Manufacturers in 2024
Figure 14. Global Pharmacovigilance (Pv) Outsourcing Revenue Share by Manufacturers in 2024
Figure 15. Pharmacovigilance (Pv) Outsourcing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Pharmacovigilance (Pv) Outsourcing Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pharmacovigilance (Pv) Outsourcing Revenue in 2024
Figure 18. Industry Chain Map of Pharmacovigilance (Pv) Outsourcing
Figure 19. Global Pharmacovigilance (Pv) Outsourcing Market PEST Analysis
Figure 20. Global Pharmacovigilance (Pv) Outsourcing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Pharmacovigilance (Pv) Outsourcing Market Share by Type
Figure 27. Sales Market Share of Pharmacovigilance (Pv) Outsourcing by Type (2020-2025)
Figure 28. Sales Market Share of Pharmacovigilance (Pv) Outsourcing by Type in 2024
Figure 29. Market Size Share of Pharmacovigilance (Pv) Outsourcing by Type (2020-2025)
Figure 30. Market Size Share of Pharmacovigilance (Pv) Outsourcing by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Pharmacovigilance (Pv) Outsourcing Market Share by Application
Figure 33. Global Pharmacovigilance (Pv) Outsourcing Sales Market Share by Application (2020-2025)
Figure 34. Global Pharmacovigilance (Pv) Outsourcing Sales Market Share by Application in 2024
Figure 35. Global Pharmacovigilance (Pv) Outsourcing Market Share by Application (2020-2025)
Figure 36. Global Pharmacovigilance (Pv) Outsourcing Market Share by Application in 2024
Figure 37. Global Pharmacovigilance (Pv) Outsourcing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Pharmacovigilance (Pv) Outsourcing Sales Market Share by Region (2020-2025)
Figure 39. Global Pharmacovigilance (Pv) Outsourcing Market Size Market Share by Region (2020-2025)
Figure 40. North America Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Pharmacovigilance (Pv) Outsourcing Sales Market Share by Country in 2024
Figure 43. North America Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Pharmacovigilance (Pv) Outsourcing Market Size Market Share by Country in 2024
Figure 45. U.S. Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Pharmacovigilance (Pv) Outsourcing Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Pharmacovigilance (Pv) Outsourcing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Pharmacovigilance (Pv) Outsourcing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Pharmacovigilance (Pv) Outsourcing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Pharmacovigilance (Pv) Outsourcing Sales Market Share by Country in 2024
Figure 53. Europe Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Pharmacovigilance (Pv) Outsourcing Market Size Market Share by Country in 2024
Figure 55. Germany Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Pharmacovigilance (Pv) Outsourcing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Pharmacovigilance (Pv) Outsourcing Market Size Market Share by Region in 2024
Figure 68. China Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (K MT)
Figure 79. South America Pharmacovigilance (Pv) Outsourcing Sales Market Share by Country in 2024
Figure 80. South America Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (M USD)
Figure 81. South America Pharmacovigilance (Pv) Outsourcing Market Size Market Share by Country in 2024
Figure 82. Brazil Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Pharmacovigilance (Pv) Outsourcing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Pharmacovigilance (Pv) Outsourcing Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Pharmacovigilance (Pv) Outsourcing Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Pharmacovigilance (Pv) Outsourcing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Pharmacovigilance (Pv) Outsourcing Production Market Share by Region (2020-2025)
Figure 103. North America Pharmacovigilance (Pv) Outsourcing Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Pharmacovigilance (Pv) Outsourcing Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Pharmacovigilance (Pv) Outsourcing Production (K MT) Growth Rate (2020-2025)
Figure 106. China Pharmacovigilance (Pv) Outsourcing Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Pharmacovigilance (Pv) Outsourcing Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Pharmacovigilance (Pv) Outsourcing Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Pharmacovigilance (Pv) Outsourcing Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Pharmacovigilance (Pv) Outsourcing Market Share Forecast by Type (2026-2033)
Figure 111. Global Pharmacovigilance (Pv) Outsourcing Sales Forecast by Application (2026-2033)
Figure 112. Global Pharmacovigilance (Pv) Outsourcing Market Share Forecast by Application (2026-2033)
